Valeo Pharmainc (VPH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in thousands)
| 10-2018 | 10-2017 | |
| Sales | 4,382 | 1,277 |
| Cost of Goods | 3,549 | 747 |
| Gross Profit | 833 | 530 |
| Operating Expenses | 3,261 | 3,145 |
| Operating Income | -2,428 | -2,615 |
| Interest Expense | 174 | 102 |
| Other Income | 202 | -1,783 |
| Pre-tax Income | -2,400 | -4,500 |
| Income Tax | 37 | -881 |
| Net Income Continuous | -2,437 | -3,619 |
| Net Income | $-2,437 | $-3,619 |
| EPS Basic Total Ops | -0.05 | -0.07 |
| EPS Diluted Total Ops | -0.05 | -0.07 |
| EBITDA(a) | $-2,182 | $-4,357 |